NASH: A Call to Action
Steering Committee
Chair
Fasiha Kanwal, MD, MSHS
Gastroenterology
Baylor College of Medicine
Co-Chair
Kenneth Cusi, MD
Endocrinology
University of Florida
Co-Chair
Jay Shubrook, DO
Family Medicine
Touro University
Program Overview
Initiative
The NASH: A Call to Action is an ongoing, multidisciplinary effort to align clinicians on best practices to improve the screening, diagnosis, and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).
Audience
Gastroenterologists, endocrinologists, primary care practitioners
Supporters
The NASH: A Call-to-Action initiative is supported by independent medical education grants from Intercept Pharmaceuticals, Inc., Pfizer Inc., Novo Nordisk Inc., Allergan, and Genfit.
Program Elements
Conducted among 751 multidisciplinary physicians to gauge awareness of NAFLD, NASH, and the screening and diagnostic tools available.
NASH: A Call-to-Action Consensus Conference
AGA convened global leaders in gastroenterology, hepatology, endocrinology and primary care to align on an action plan to prepare clinicians for the NASH epidemic.
Preparing for the NASH Epidemic: A Call-to-Action Consensus Report
Co-published in Gastroenterology, Diabetes Care, Metabolism, and Obesity, the paper recommended developing a clinical care pathway that uses validated and efficient noninvasive tests and calculators to support a multidisciplinary approach to screening, diagnosis and management of NAFLD/NASH.
NASH: Take Action! CME Podcast
6-episode podcast series provided CME and featured interviews with world-renowned experts in NAFLD, NASH and metabolic syndrome on screening, diagnosing and managing these conditions.
Published in Gastroenterology to provide practical guidance across the spectrum of care from screening and diagnosis to management of patients with NAFLD and NASH, facilitating value-based, efficient, and safe care that is consistent with evidence-based guidelines.
The Let's Smash NASH! clinical care pathway mobile app is a tool for use at the point-of-care, providing evidence-based recommendations about the timing, sequence and provision of interventions, assisting practitioners in identifying, evaluating and managing patients with NASH.
Let’s Smash NASH! DDW Symposium
Led by a multidisciplinary faculty, case-study based CME program used the clinical care pathway mobile app with enduring material.
Program partner:
In collaboration with:
